Hormone Refractory Prostate Cancer (HRPCA) Market Size and Opportunity Analysis The Hormone Refractory Prostate Cancer (HRPCA) market has shown significant growth in recent years due to increasing prevalence and the demand for advanced therapeutic options. As of 2024, the global HRPCA market is valued at approximately $7.5 billion. This growth […]
Recent News